5-HT3 receptor antagonists block cocaine-induced locomotion via a PCPA-sensitive mechanism

Adena L. Svingos, Robert Hitzemann

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

We report results in rats pretreated with (±)-zacopride (0.03 mg/kg, IP), ICS 205-930 (0.1 mg/kg, IP), and MDL 72222 (1.0 mg/kg, IP) 15 min before challenge with (-)-cocaine (10.0 mg/kg, IP). At a dose of 10 μg/kg, zacopride significantly inhibited (approximately 50%) cocaine-induced locomotion. We also investigated whether or not 5-hydroxytryptamine3 (5-HT3) antagonists block the cocaine binding site on the dopamine transporter and/or affect the ability of dopamine to regulate this binding site. In well-washed striatal membranes, neither zacopride nor ICS 205-930 (10-9-10-5 M) inhibited [3H]2β-carbomethoxy-3β-(4-fluorophenyl)tropane ([3H]WIN 35,428) (0.3 nM) binding. Furthermore, neither of these compounds affected the ability of dopamine to block WIN 35,428 binding. To determine if 5-HT is required for the 5-HT3 antagonist effect, we examined the interaction between cocaine and zacopride in rats pretreated with p-chlorophenylalanine (PCPA) (3 days × 100 mg/kg/day). PCPA pretreatment shifted the cocaine dose-response curve to the right and blocked the ability of zacopride to reverse cocaine-induced activity.

Original languageEnglish (US)
Pages (from-to)871-879
Number of pages9
JournalPharmacology, Biochemistry and Behavior
Volume43
Issue number3
DOIs
StatePublished - 1992
Externally publishedYes

Fingerprint

Fenclonine
Locomotion
Cocaine
tropisetron
Rats
Dopamine
Binding Sites
Corpus Striatum
Dopamine Plasma Membrane Transport Proteins
Serotonin
zacopride
Membranes

Keywords

  • 5-HT antagonists
  • Behavior
  • Cocaine
  • Dopamine transporter
  • PCPA
  • Rat
  • Serotonin

ASJC Scopus subject areas

  • Biochemistry
  • Behavioral Neuroscience
  • Pharmacology

Cite this

5-HT3 receptor antagonists block cocaine-induced locomotion via a PCPA-sensitive mechanism. / Svingos, Adena L.; Hitzemann, Robert.

In: Pharmacology, Biochemistry and Behavior, Vol. 43, No. 3, 1992, p. 871-879.

Research output: Contribution to journalArticle

@article{25d6eec7265944c1a559e50c411a4fd9,
title = "5-HT3 receptor antagonists block cocaine-induced locomotion via a PCPA-sensitive mechanism",
abstract = "We report results in rats pretreated with (±)-zacopride (0.03 mg/kg, IP), ICS 205-930 (0.1 mg/kg, IP), and MDL 72222 (1.0 mg/kg, IP) 15 min before challenge with (-)-cocaine (10.0 mg/kg, IP). At a dose of 10 μg/kg, zacopride significantly inhibited (approximately 50{\%}) cocaine-induced locomotion. We also investigated whether or not 5-hydroxytryptamine3 (5-HT3) antagonists block the cocaine binding site on the dopamine transporter and/or affect the ability of dopamine to regulate this binding site. In well-washed striatal membranes, neither zacopride nor ICS 205-930 (10-9-10-5 M) inhibited [3H]2β-carbomethoxy-3β-(4-fluorophenyl)tropane ([3H]WIN 35,428) (0.3 nM) binding. Furthermore, neither of these compounds affected the ability of dopamine to block WIN 35,428 binding. To determine if 5-HT is required for the 5-HT3 antagonist effect, we examined the interaction between cocaine and zacopride in rats pretreated with p-chlorophenylalanine (PCPA) (3 days × 100 mg/kg/day). PCPA pretreatment shifted the cocaine dose-response curve to the right and blocked the ability of zacopride to reverse cocaine-induced activity.",
keywords = "5-HT antagonists, Behavior, Cocaine, Dopamine transporter, PCPA, Rat, Serotonin",
author = "Svingos, {Adena L.} and Robert Hitzemann",
year = "1992",
doi = "10.1016/0091-3057(92)90420-K",
language = "English (US)",
volume = "43",
pages = "871--879",
journal = "Pharmacology Biochemistry and Behavior",
issn = "0091-3057",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - 5-HT3 receptor antagonists block cocaine-induced locomotion via a PCPA-sensitive mechanism

AU - Svingos, Adena L.

AU - Hitzemann, Robert

PY - 1992

Y1 - 1992

N2 - We report results in rats pretreated with (±)-zacopride (0.03 mg/kg, IP), ICS 205-930 (0.1 mg/kg, IP), and MDL 72222 (1.0 mg/kg, IP) 15 min before challenge with (-)-cocaine (10.0 mg/kg, IP). At a dose of 10 μg/kg, zacopride significantly inhibited (approximately 50%) cocaine-induced locomotion. We also investigated whether or not 5-hydroxytryptamine3 (5-HT3) antagonists block the cocaine binding site on the dopamine transporter and/or affect the ability of dopamine to regulate this binding site. In well-washed striatal membranes, neither zacopride nor ICS 205-930 (10-9-10-5 M) inhibited [3H]2β-carbomethoxy-3β-(4-fluorophenyl)tropane ([3H]WIN 35,428) (0.3 nM) binding. Furthermore, neither of these compounds affected the ability of dopamine to block WIN 35,428 binding. To determine if 5-HT is required for the 5-HT3 antagonist effect, we examined the interaction between cocaine and zacopride in rats pretreated with p-chlorophenylalanine (PCPA) (3 days × 100 mg/kg/day). PCPA pretreatment shifted the cocaine dose-response curve to the right and blocked the ability of zacopride to reverse cocaine-induced activity.

AB - We report results in rats pretreated with (±)-zacopride (0.03 mg/kg, IP), ICS 205-930 (0.1 mg/kg, IP), and MDL 72222 (1.0 mg/kg, IP) 15 min before challenge with (-)-cocaine (10.0 mg/kg, IP). At a dose of 10 μg/kg, zacopride significantly inhibited (approximately 50%) cocaine-induced locomotion. We also investigated whether or not 5-hydroxytryptamine3 (5-HT3) antagonists block the cocaine binding site on the dopamine transporter and/or affect the ability of dopamine to regulate this binding site. In well-washed striatal membranes, neither zacopride nor ICS 205-930 (10-9-10-5 M) inhibited [3H]2β-carbomethoxy-3β-(4-fluorophenyl)tropane ([3H]WIN 35,428) (0.3 nM) binding. Furthermore, neither of these compounds affected the ability of dopamine to block WIN 35,428 binding. To determine if 5-HT is required for the 5-HT3 antagonist effect, we examined the interaction between cocaine and zacopride in rats pretreated with p-chlorophenylalanine (PCPA) (3 days × 100 mg/kg/day). PCPA pretreatment shifted the cocaine dose-response curve to the right and blocked the ability of zacopride to reverse cocaine-induced activity.

KW - 5-HT antagonists

KW - Behavior

KW - Cocaine

KW - Dopamine transporter

KW - PCPA

KW - Rat

KW - Serotonin

UR - http://www.scopus.com/inward/record.url?scp=0026613712&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026613712&partnerID=8YFLogxK

U2 - 10.1016/0091-3057(92)90420-K

DO - 10.1016/0091-3057(92)90420-K

M3 - Article

C2 - 1448481

AN - SCOPUS:0026613712

VL - 43

SP - 871

EP - 879

JO - Pharmacology Biochemistry and Behavior

JF - Pharmacology Biochemistry and Behavior

SN - 0091-3057

IS - 3

ER -